If they are interested in medical cannabis, perhaps they might consider a small acquisition (to get started), and maybe buy the Little Green Pharma (LGP).
Yes, I agree, they should get their Australian MC license, and then be prudent with MC investment funding in Australia post that.
Australia should move to legislate CBD in line with Europe and North America, our politicians are weak and paranoid, and our CBD legislation is draconian.
Little Green Pharma
Gw
Ann: Elixinol Global 1H FY2018 results conference call, page-12
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.002(33.3%) |
Mkt cap ! $6.605M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $2.103K | 475.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 7670493 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 924824 | 4 |
View Market Depth
| Last trade - 14.04pm 29/11/2024 (20 minute delay) ? |
| EXL (ASX) Chart |
